Preclinical status of macromomycin at the National Cancer Institute.
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D001426:Bacterial Proteins / Q000627:therapeutic use; D002277:Carcinoma / Q000188:drug therapy; D002478:Cells, Cultured; D004353:Drug Evaluation, Preclinical; D004355:Drug Stability; D007939:Leukemia L1210 / Q000188:drug therapy; D007942:Leukemia, Experimental / Q000188:drug therapy; D008175:Lung Neoplasms / Q000188:drug therapy; D008545:Melanoma / Q000188:drug therapy; D009362:Neoplasm Metastasis; D009374:Neoplasms, Experimental / Q000188:drug therapy; D051381:Rats
D000903:Antibiotics, Antineoplastic; D001426:Bacterial Proteins